Gary Sender

CIK 1659085 · Chief Financial Officer · last filed 2026-06-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$401.0K

Companies

4

Total Filings

44

Lifetime Open-Market Net

-$1.87M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SDGR Director 25,388 $15.29 $388.2K -$1.91M 8 2026-06-23
HRMY Director $35.77 $0 7 2026-05-18
IBIO Director 9,191 $1.39 $12.8K $25.0K 5 2025-11-24
Nabriva Therapeutics plc (NBRV) Delisted Chief Financial Officer 819 $1.42 $1.2K $18.5K 23 2021-03-02

Recent Filings · Page 5 of 5

44 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-02-02 Nabriva Therapeutics plc (NBRV) Delisted Grant (A) $0 EDGAR
2017-09-26 Nabriva Therapeutics plc (NBRV) Delisted Buy (P) +2,000 $16.4K EDGAR
2017-06-28 Other (J) +2,200 $0
2017-02-09 Nabriva Therapeutics plc (NBRV) Delisted Grant (A) $0 EDGAR
Showing 4144 of 44
Page 5 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.